Gouzoulis-Mayfrank Euphrosyne, Heekeren Karsten, Voss Tatjana, Moerth Dina, Thelen Bernhard, Meincke Ulrich
Department of Psychiatry and Psychotherapy, University Hospital, Technical University of Aachen (RWTH), Pauwelsstrasse 30, Aachen D-52057, Germany.
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):389-96. doi: 10.1016/j.pnpbp.2003.11.010.
Previous cross-sectional studies on covert orienting of visual attention in schizophrenia have been inconsistent. In the present longitudinal study, we examined 40 medicated acutely ill inpatients with a covert orienting of attention task (COVAT) shortly after admission, and again 12-16 weeks after the initial examination, while most patients were in (partial) remission. We administered a COVAT with nonpredictive peripheral cues and two stimulus-onset asynchronies (SOA; 100 and 800 ms). In addition, we examined 34 healthy control subjects twice (2 weeks apart). The most important finding was a lack of inhibition of return (IOR) in patients with schizophrenia, both at the first examination in an acute psychotic state and at the follow-up examination after considerable clinical improvement. The IOR deficit was unrelated to psychopathology, length of illness, number of previous psychotic episodes, and type of neuroleptic (NL) medication. Deficient IOR in patients with schizophrenia appears to be state-independent and might be viewed as a trait or vulnerability marker of the disorder. Subsequent studies with never-medicated populations and with schizotypal or high-risk subjects are needed in order to further analyze the possible role of NL medications and to clarify whether blunted IOR might represent a vulnerability marker of schizophrenia.
先前关于精神分裂症患者视觉注意的隐蔽定向的横断面研究结果并不一致。在本纵向研究中,我们对40名药物治疗的急性病住院患者在入院后不久进行了一项注意任务的隐蔽定向测试(COVAT),并在初次检查后的12 - 16周再次进行测试,此时大多数患者处于(部分)缓解状态。我们使用了带有非预测性外周线索和两种刺激起始异步时间(SOA;100毫秒和800毫秒)的COVAT。此外,我们对34名健康对照者进行了两次测试(间隔2周)。最重要的发现是,精神分裂症患者在急性精神病状态下的首次检查以及临床显著改善后的随访检查中均缺乏返回抑制(IOR)。IOR缺陷与精神病理学、病程、既往精神病发作次数以及抗精神病药物(NL)类型无关。精神分裂症患者的IOR缺陷似乎与状态无关,可能被视为该疾病的一种特质或易感性标志物。后续需要对从未接受过药物治疗的人群以及分裂型或高危受试者进行研究,以便进一步分析NL药物的可能作用,并阐明IOR减弱是否可能代表精神分裂症的易感性标志物。